Copyright
©The Author(s) 2018.
World J Gastroenterol. Feb 7, 2018; 24(5): 623-630
Published online Feb 7, 2018. doi: 10.3748/wjg.v24.i5.623
Published online Feb 7, 2018. doi: 10.3748/wjg.v24.i5.623
Table 3 Values for serological assays
Serological assays | Mean ± SD | Median (IQRs) | Range |
GM-CSF cytokine, pg/mL | 3.18 ± 8.61 | 1.28 (0.43-3.05) | 0.0052-136.5 |
GM-CSF Ab, mcg/mL | 10.64 ± 19.76 | 3.81 (0.93-11.01) | 0.08-241.2 |
ASCA IgA, U/mL | 95.21 ± 77.38 | 67.51 (27.86-174.4) | 1.92-242.8 |
ASCA IgG, U/mL | 69.79 ± 41.09 | 66.86 (31.76-104.2) | 3.17-158.1 |
- Citation: Gathungu G, Zhang Y, Tian X, Bonkowski E, Rowehl L, Krumsiek J, Nix B, Chalk C, Trapnell B, Zhu W, Newberry R, Denson L, Li E. Impaired granulocyte-macrophage colony-stimulating factor bioactivity accelerates surgical recurrence in ileal Crohn’s disease. World J Gastroenterol 2018; 24(5): 623-630
- URL: https://www.wjgnet.com/1007-9327/full/v24/i5/623.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i5.623